ArticleNature communications2020
In vivo diversification of target genomic sites using processive base deaminase fusions blocked by dCas9.
Beatriz Álvarez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this papercites it